(Reuters) -COVID vaccine makers should price their updated shots for the fall at a reasonable rate that would reflect the benefits they received through government investments,...
Cases in Germany and the U.S. broadened by asserting additional, new intellectual property rightsThree new intellectual property rights added to infringement lawsuit against...
LONDON (Reuters) - Weight-loss drug Wegovy helped Rebecca Vogt achieve a major goal - shedding the weight she had not managed to drop since giving birth. But, after a particularly...
Biotech stocks may be one of the big winners if the Federal Reserve is almost finished raising interest rates. CRISPR Therapeutics is at the forefront of gene editing, which may be...
Wall Street kicks off the second half of 2023 with the stock market near 16-month highs after a roaring start to the year. Amid the current backdrop, I used the InvestingPro stock...
Here is your Pro Recap of the top takeaways from Wall Street analysts for the past week: downgrades for Tesla and Pfizer, upgrades for Nvidia and Pinterest, and an outperform...
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women’s health under the Eliquis, Nurtec ODT/Vydura, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Retacrit, Lorbrena, and Braftovi brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc., as well as strategic partnership with CSPC Pharmaceutical Group Limited to launch a local brand of the COVID-19 oral therapeutic treatment Nirmatrelvir/Ritonavir in China, and a collaboration with Carrick Therapeutics Limited. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
| Average | 46.22 (+28.18% Upside) |
| High | 75.00 |
| Low | 35.00 |
| Price | 36.06 |
| No. of Analysts | 26 |
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Buy | Buy | Strong Sell | Sell | Strong Sell |
| Technical Indicators | Strong Buy | Buy | Sell | Strong Sell | Strong Sell |
| Summary | Strong Buy | Buy | Strong Sell | Strong Sell | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 277.90 | 279.45 | 270.60 | +5.91 | +2.17% | 109.19M | NASDAQ | |||
| 459.83 | 461.55 | 444.92 | +20.82 | +4.74% | 46.90M | NASDAQ | |||
| 190.56 | 191.19 | 189.78 | +0.79 | +0.42% | 40.13M | NASDAQ | |||
| 115.92 | 116.16 | 113.57 | +1.34 | +1.17% | 48.75M | NASDAQ | |||
| 10.76 | 11.32 | 10.72 | -0.40 | -3.58% | 59.29M | NYSE | |||
| 117.45 | 118.58 | 116.76 | +1.43 | +1.23% | 9.21M | NYSE | |||
| 96.61 | 97.00 | 94.60 | +2.61 | +2.78% | 23.31M | NYSE | |||
| 16.74 | 17.26 | 16.63 | +0.15 | +0.90% | 58.00M | NYSE | |||
| 51.53 | 51.62 | 50.65 | +0.79 | +1.56% | 17.44M | NASDAQ | |||
| 33.87 | 34.30 | 33.62 | -0.11 | -0.32% | 30.04M | NASDAQ | |||
| 124.54 | 124.83 | 120.45 | +5.61 | +4.72% | 43.69M | NASDAQ | |||
| 9.16 | 9.24 | 8.77 | -0.04 | -0.43% | 42.98M | NASDAQ | |||
| 313.41 | 316.24 | 310.29 | +4.07 | +1.32% | 30.13M | NASDAQ | |||
| 90.47 | 90.81 | 89.08 | +0.32 | +0.35% | 15.23M | NYSE | |||
| 39.65 | 41.68 | 39.55 | -0.57 | -1.42% | 19.55M | NYSE |